← Open Payments lookup

MARK FLOOD: Open Payments

NPI 1376729046 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$976 in 74 payments from 14 companies in 2025. Trend: 2023 $1,810 · 2024 $1,274 · 2025 $976

Food & beverage: $976
CompanyPaymentsAmount
AbbVie Inc.26$181
Teva Pharmaceuticals USA, Inc.11$181
Neurocrine BioSciences, Inc.9$139
Vanda Pharmaceuticals Inc.8$133
Alkermes, Inc.4$78
Neos Therapeutics, LP3$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
Tris Pharma Inc2$37
Lundbeck LLC2$32
Axsome Therapeutics, Inc.2$32

Products named: VRAYLAR, AUSTEDO XR, INGREZZA, FANAPT, ARISTADA, CAPLYTA, Dyanavel XR, HETLIOZ.

Industry payments across NJ — which companies pay providers there.